Pharsight

Drugs that contain Temozolomide

1. Temodar patents expiration

TEMODAR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8623868 MERCK SHARP DOHME Processes of making and using pharmaceutical formulations of antineoplastic agents
Feb, 2023

(1 year, 3 days ago)

US7786118 MERCK SHARP DOHME Pharmaceutical formulations of antineoplastic agents
Feb, 2023

(1 year, 3 days ago)

US6987108 MERCK SHARP DOHME Pharmaceutical formulations of antineoplastic agents and processes of making and using the same
Sep, 2023

(5 months ago)

Market Authorisation Date: 27 February, 2009

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

TEMODAR family patents

Family Patents